Clinical Trial Update: A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating fezolinetant for reducing hot flashes in menopausal women has completed and posted results in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• Fezolinetant (Veozah) (fezolinetant)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Hot Flashes | Phase 3 | Status: COMPLETED | Results posted: 2022-08-12